Related Experiment Video
Updated: Jun 23, 2026
09:03
Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies
Published on: June 30, 2023
Perlecan regulates developmental angiogenesis by modulating the VEGF-VEGFR2 axis
Jason J Zoeller1, John M Whitelock, Renato V Iozzo
1Department of Pathology, Anatomy and Cell Biology, and the Cancer Cell Biology and Signaling Program, Kimmel Cancer Center, Thomas Jefferson University, 1020 Locust Street, Philadelphia, PA 19107, USA.
Summary
Perlecan is essential for blood vessel development by regulating endothelial cell migration and proliferation. It coordinates developmental angiogenesis by modulating vascular endothelial growth factor (VEGF) signaling.
Area of Science:
- Developmental Biology
- Molecular Biology
- Cell Biology
Background:
- Perlecan is a crucial component of the vascular basement membrane.
- Angiogenesis, the formation of new blood vessels, is vital for development and disease.
- Vascular Endothelial Growth Factor (VEGF) signaling is a primary driver of angiogenesis.
Purpose of the Study:
- To elucidate the specific functions of perlecan in developmental angiogenesis.
- To investigate the relationship between perlecan and the VEGF signaling pathway.
- To understand how perlecan influences endothelial cell behavior during blood vessel formation.
Main Methods:
- Zebrafish model system for studying angiogenesis.
- Perlecan knockdown via morpholino injection.
- Microinjection of VEGF-A(165) protein or mRNA for rescue experiments.
- Biochemical assays to assess perlecan-VEGF-A binding and VEGFR2 activation.
Main Results:
- Perlecan is required for proper endothelial cell migration and proliferation.
- Perlecan knockdown leads to abnormal VEGF-A protein distribution.
- Perlecan knockdown phenotypes were rescued by VEGF-A(165) administration.
- Perlecan binds VEGF-A(165) in a heparan sulfate-dependent manner.
- Perlecan enhances VEGF-mediated VEGFR2 activation in endothelial cells.
Conclusions:
- Perlecan plays a central role in coordinating developmental angiogenesis.
- Perlecan modulates VEGF-VEGFR2 signaling by regulating VEGF-A localization and activity.
- Understanding perlecan's function offers insights into therapeutic strategies for angiogenesis-related conditions.
Related Concept Videos
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:10Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
01:07Development of Blood Vessels
The development of the vascular system in a fetus is a complex and intricate process that begins as early as 15 to 16 days post-conception. This process starts outside the embryo, specifically in the mesoderm of the yolk sac, chorion, and connecting stalk. Approximately two days later, the formation of blood vessels occurs within the embryo itself.
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...